PMID- 16368252 OWN - NLM STAT- MEDLINE DCOM- 20061017 LR - 20161018 IS - 1063-4584 (Print) IS - 1063-4584 (Linking) VI - 14 IP - 5 DP - 2006 May TI - Downregulation of inhibitor of apoptosis proteins in apoptotic human chondrocytes treated with tumor necrosis factor-alpha and actinomycin D. PG - 435-41 AB - OBJECTIVE: Apoptosis of chondrocytes plays a pivotal role in cartilage degeneration. Tumor necrosis factor-alpha (TNF-alpha) is a proinflammatory cytokine and has been assumed to cause the degradation of human cartilage. To investigate the mechanisms of TNF-alpha-mediated apoptosis of human chondrocytes from a point of view of the balance between the caspase-cascade and the expression of inhibitor of apoptosis proteins (IAPs), although both of them are induced with TNF-signals. METHODS: The expression of TNF-receptors (TNF-Rs) in normal human articular chondrocyte (NHAC-kn) was examined with immunocytochemistry. Subconfluent cultures of NHAC-kn were tested with TNF-alpha and/or actinomycin D (actD), and the induction of apoptosis was evaluated by the frequency of apoptotic cells visualized with nuclear staining using Hoechst 33342. The activation of caspases and the expression of IAPs were examined with Western blot analyses. RESULTS: NHAC-kn expressed TNF-R1 and -R2. When NHAC-kn was treated with TNF-alpha (10 ng/ml) and actD (0.2 microg/ml) for 24 h, the frequency of apoptotic cells increased to more than 25%. TNF-alpha alone, however, induced the apoptosis insufficiently (up to 8.3%), even when used at the concentration of 100 ng/ml for 48 h. In apoptotic human chondrocytes induced with TNF-alpha (10 ng/ml) and actD (0.2 microg/ml), the caspase-3, -8, and -9 were activated and the protein expression of XIAP and c-IAP1 decreased. CONCLUSIONS: In apoptotic human chondrocytes induced with TNF-alpha and actD, the balance between caspase activation and IAPs' expression lay with the executioner caspase (caspase-3) and led to decreased expression of XIAP and c-IAP1. FAU - Yoshimura, F AU - Yoshimura F AD - Department of Pathology, Iwate Medical University School of Medicine, 19-1 Uchimaru, Morioka 020-8505, Japan. FAU - Kanno, H AU - Kanno H FAU - Uzuki, M AU - Uzuki M FAU - Tajima, K AU - Tajima K FAU - Shimamura, T AU - Shimamura T FAU - Sawai, T AU - Sawai T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20051220 PL - England TA - Osteoarthritis Cartilage JT - Osteoarthritis and cartilage JID - 9305697 RN - 0 (Protein Synthesis Inhibitors) RN - 0 (Receptors, Tumor Necrosis Factor) RN - 0 (Recombinant Proteins) RN - 0 (Tumor Necrosis Factor-alpha) RN - 1CC1JFE158 (Dactinomycin) RN - EC 3.4.22.- (Caspases) SB - IM MH - Apoptosis/*physiology MH - Blotting, Western/methods MH - Caspases/metabolism MH - Cells, Cultured MH - Chondrocytes/*drug effects MH - Dactinomycin/*pharmacology MH - Down-Regulation/physiology MH - Enzyme Activation/drug effects MH - Humans MH - Immunohistochemistry/methods MH - Protein Synthesis Inhibitors/*pharmacology MH - Receptors, Tumor Necrosis Factor/analysis MH - Recombinant Proteins/pharmacology MH - Signal Transduction/drug effects MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 2005/12/22 09:00 MHDA- 2006/10/18 09:00 CRDT- 2005/12/22 09:00 PHST- 2005/09/29 00:00 [received] PHST- 2005/11/07 00:00 [accepted] PHST- 2005/12/22 09:00 [pubmed] PHST- 2006/10/18 09:00 [medline] PHST- 2005/12/22 09:00 [entrez] AID - S1063-4584(05)00315-8 [pii] AID - 10.1016/j.joca.2005.11.003 [doi] PST - ppublish SO - Osteoarthritis Cartilage. 2006 May;14(5):435-41. doi: 10.1016/j.joca.2005.11.003. Epub 2005 Dec 20.